To systematically examine the global impact of co-targeting therapy on the PDAC stroma and immune microenvironment, tumor tissues were collected from vehicle-, Gem-, and Gem+PPIX+Cel-treated mice bearing KPC mT3-induced PDACs for scRNA-seq analyses (Fig. 7; Supplementary Figs. S12, S13). This evidence concerns the gene GEM and neoplasm.